PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
BRIEF published on 05/06/2025 at 07:35, 1 year 4 months ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
BRIEF published on 05/06/2025 at 07:35, 1 year 4 months ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
BRIEF published on 04/25/2025 at 07:35, 1 year 4 months ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
BRIEF published on 04/25/2025 at 07:35, 1 year 4 months ago Présentation de Sensorion sur la thérapie génique lors de la réunion annuelle de l'ASPO 2025 Essai Clinique Thérapie Génique Perte Auditive SENS-501 Oto-rhino-laryngologie Pédiatrique
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion annonce la participation du Dr. Natalie Loundon à la réunion annuelle de la Société américaine d'oto-rhino-laryngologie pédiatrique pour présenter la thérapie génique SENS-501 pour la perte auditive Thérapie Génique Sensorion Perte Auditive Dr. Natalie Loundon ASPO
Published on 09/08/2026 at 01:45, 4 hours 15 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 1 hour ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 6 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 7 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 7 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 10 hours 41 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 11 hours ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 11 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 12 hours ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 12 hours 15 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 11 hours ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 11 hours ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 11 hours 55 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 11 hours 55 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
